Cutler Group LP Blueprint Medicines Corp Transaction History

Cutler Group LP

$307 Million
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$46.9 - $66.0 $44,273 - $62,304	944 Added 1685.71%	1,000 $50,000
Q2 2023 Jul 18, 2023	SELL	$42.2 - $66.37 $73,596 - $115,749	-1,744 Reduced 96.89%	56 $3,000
Q3 2022 Oct 25, 2022	SELL	$49.93 - $77.7 $159,776 - $248,640	-3,200 Reduced 64.0%	1,800 $118,000
Q2 2022 Aug 04, 2022	BUY	$45.23 - $70.15 $165,541 - $256,749	3,660 Added 273.13%	5,000 $252,000
Q1 2022 Apr 14, 2022	SELL	$54.1 - $110.08 $35,706 - $72,652	-660 Reduced 33.0%	1,340 $85,000
Q4 2021 Jan 18, 2022	SELL	$94.25 - $115.99 $94,250 - $115,990	-1,000 Reduced 33.33%	2,000 $214,000
Q3 2021 Oct 26, 2021	SELL	$80.98 - $109.47 $51,827 - $70,060	-640 Reduced 17.58%	3,000 $308,000
Q1 2021 Apr 26, 2021	BUY	$90.71 - $108.28 $248,545 - $296,687	2,740 Added 304.44%	3,640 $353,000
Q2 2020 Jul 22, 2020	SELL	$57.09 - $79.27 $57,090 - $79,270	-1,000 Reduced 52.63%	900 $70,000
Q1 2020 May 07, 2020	BUY	$48.11 - $82.22 $33,677 - $57,554	700 Added 58.33%	1,900 $111,000
Q4 2019 Feb 06, 2020	SELL	$66.73 - $82.59 $266,920 - $330,360	-4,000 Reduced 76.92%	1,200 $96,000
Q3 2019 Oct 28, 2019	BUY	$72.9 - $101.41 $239,112 - $332,624	3,280 Added 170.83%	5,200 $382,000
Q2 2019 Aug 09, 2019	SELL	$73.54 - $97.8 $108,839 - $144,744	-1,480 Reduced 43.53%	1,920 $181,000
Q1 2019 May 10, 2019	BUY	$48.7 - $86.6 $43,830 - $77,940	900 Added 36.0%	3,400 $272,000
Q4 2018 Feb 05, 2019	BUY	$45.57 - $74.26 $50,127 - $81,686	1,100 Added 78.57%	2,500 $134,000
Q3 2018 Nov 07, 2018	SELL	$58.91 - $78.32 $23,564 - $31,327	-400 Reduced 22.22%	1,400 $109,000
Q2 2018 Aug 10, 2018	BUY	$60.96 - $101.18 $109,728 - $182,124	1,800 New	1,800 $114,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$612 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$609 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$494 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$363 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$253 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account